JP2016520803A5 - - Google Patents

Download PDF

Info

Publication number
JP2016520803A5
JP2016520803A5 JP2016502475A JP2016502475A JP2016520803A5 JP 2016520803 A5 JP2016520803 A5 JP 2016520803A5 JP 2016502475 A JP2016502475 A JP 2016502475A JP 2016502475 A JP2016502475 A JP 2016502475A JP 2016520803 A5 JP2016520803 A5 JP 2016520803A5
Authority
JP
Japan
Prior art keywords
mirna
cancer
level
subject
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502475A
Other languages
English (en)
Japanese (ja)
Other versions
JP6554458B2 (ja
JP2016520803A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/027541 external-priority patent/WO2014152622A1/en
Publication of JP2016520803A publication Critical patent/JP2016520803A/ja
Publication of JP2016520803A5 publication Critical patent/JP2016520803A5/ja
Application granted granted Critical
Publication of JP6554458B2 publication Critical patent/JP6554458B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502475A 2013-03-15 2014-03-14 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス Active JP6554458B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361791301P 2013-03-15 2013-03-15
US61/791,301 2013-03-15
PCT/US2014/027541 WO2014152622A1 (en) 2013-03-15 2014-03-14 Mirna biogenesis in exosomes for diagnosis and therapy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2018108450A Division JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Publications (3)

Publication Number Publication Date
JP2016520803A JP2016520803A (ja) 2016-07-14
JP2016520803A5 true JP2016520803A5 (enExample) 2017-04-13
JP6554458B2 JP6554458B2 (ja) 2019-07-31

Family

ID=51581257

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2016502475A Active JP6554458B2 (ja) 2013-03-15 2014-03-14 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス
JP2018108450A Active JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2018108450A Active JP6807351B2 (ja) 2013-03-15 2018-06-06 診断及び治療のためのエクソソームにおけるｍｉＲＮＡバイオジェネシス

Country Status (15)

Country Link
US (2) US20160024503A1 (enExample)
EP (2) EP2971162B1 (enExample)
JP (2) JP6554458B2 (enExample)
KR (1) KR102183406B1 (enExample)
CN (2) CN109852695B (enExample)
AU (2) AU2014239309B2 (enExample)
BR (1) BR112015023275B1 (enExample)
CA (2) CA2905081C (enExample)
ES (1) ES2966571T3 (enExample)
HK (1) HK1218143A1 (enExample)
IL (2) IL241409B (enExample)
MX (2) MX373957B (enExample)
PT (1) PT3527670T (enExample)
RU (2) RU2018101152A (enExample)
WO (1) WO2014152622A1 (enExample)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2016150475A1 (en) * 2015-03-22 2016-09-29 Universite De Liege Circulating micrornas for the diagnosis of breast cancer
CN104774966B (zh) * 2015-05-01 2017-07-28 北京博奥医学检验所有限公司 肺腺癌miRNA标记物
CA2988585A1 (en) 2015-06-10 2016-12-15 Raghu Kalluri Use of exosomes for the treatment of disease
CN107151661A (zh) * 2016-03-02 2017-09-12 上海润腾生物科技有限公司 一种人外泌体蛋白、试剂盒及其应用
CN106202984B (zh) * 2016-08-26 2018-09-04 赵毅 一种基于多层复杂网络对肿瘤miRNA标志物的筛选方法
WO2018071806A1 (en) * 2016-10-13 2018-04-19 University Of Louisville Research Foundation, Inc. Exosomal biomarkers for diagnosis and prognosis of cancer and related methods
CN110024037B (zh) 2016-11-30 2023-06-27 微软技术许可有限责任公司 经由连接的dna随机存取存储系统
US10793897B2 (en) * 2017-02-08 2020-10-06 Microsoft Technology Licensing, Llc Primer and payload design for retrieval of stored polynucleotides
US11377699B2 (en) * 2017-11-30 2022-07-05 Provincial Health Services Authority Methods for evaluating head and neck cancers
JP7474702B2 (ja) 2018-03-28 2024-04-25 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム エキソソームから単離されたｄｎａにおけるエピジェネティック変化の同定法
KR20210005031A (ko) 2018-03-29 2021-01-13 테크니온 리서치 엔드 디벨로프먼트 화운데이션 엘티디. Pten 억제제를 포함하는 소포 및 이의 용도
TWI805739B (zh) * 2018-04-17 2023-06-21 臺北榮民總醫院 阻斷緊迫導致腫瘤生成之方法
JP7462227B2 (ja) * 2018-04-25 2024-04-05 東レ株式会社 膀胱がんの検出のためのキット、デバイス及び方法
US12339205B2 (en) 2018-10-17 2025-06-24 H.U. Group Research Institute G. K. Method for recovering extracellular vesicles
US11766484B2 (en) 2019-01-03 2023-09-26 International Business Machines Corporation Exosome vessels for delivery of molecular cargo
AU2020217747B2 (en) 2019-02-08 2025-01-02 Board Of Regents, The University Of Texas System Telomerase-containing exosomes for treatment of diseases associated with aging and age-related organ dysfunction
WO2020163553A1 (en) * 2019-02-08 2020-08-13 Virginia Commonwealth University Mda-7/il-24 for cancer treatment and methods of monitoring same
CN118512468A (zh) * 2019-02-26 2024-08-20 首尔大学校产学协力团 包含末端尿苷酰基转移酶4/7表达调控因子的用于预防或治疗癌症的药学组合物
MX2022000074A (es) * 2019-07-02 2022-04-06 Ohio State Innovation Foundation Terapias para enfermedades neurodegenerativas que usan el eje piel cerebro.
US20220275455A1 (en) * 2019-07-08 2022-09-01 Preferred Networks, Inc. Data processing and classification for determining a likelihood score for breast disease
CN110358835A (zh) * 2019-07-26 2019-10-22 泗水县人民医院 生物标志物在胃癌检测、诊断中的应用
KR102212699B1 (ko) * 2019-08-12 2021-02-05 한국원자력의학원 유방암 예방 또는 치료용 조성물
CN110607361A (zh) * 2019-10-08 2019-12-24 南京市儿童医院 miR-431作为靶点在制备促进SP表达的药物中的应用
EP4067472A4 (en) 2019-12-23 2023-12-27 Fujirebio Inc. METHOD FOR OBTAINING EXTRACELLULAR VESICLES AND BLOOD COLLECTION TUBE
EP3862442A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna in liquid biopsy
EP3862441A3 (en) * 2020-02-04 2021-10-27 Artemisia S.p.A. Method for the early diagnosis of cancer by means of ddpcr analysis of mirna and protein markers in liquid biopsy
KR102318328B1 (ko) * 2020-04-13 2021-10-27 고려대학교 산학협력단 Gcc2 단백질을 과발현하는 엑소좀 기반 암 진단 또는 예후 예측용 마커 조성물
US20230227916A1 (en) 2020-04-15 2023-07-20 H.U. Group Research Institute G.K. Method for recovering extracellular vesicle
CN111920961B (zh) * 2020-08-14 2023-09-08 福建医科大学附属协和医院 一种治疗癌症的药物
JP7662161B2 (ja) * 2020-09-08 2025-04-15 ウロテック． カンパニー リミテッド 前立腺癌診断スコアを算出するための方法及びそれの使用
KR102497196B1 (ko) 2020-09-08 2023-02-07 (주)유로테크 전립선암 진단 점수 계산 방법 및 그 용도
JP7460203B2 (ja) * 2020-11-11 2024-04-02 国立研究開発法人物質・材料研究機構 細胞で産生された膜小胞に由来する塩基配列を解析する方法、その装置、及び、そのプログラム
CN112662752B (zh) * 2021-01-18 2022-08-23 中国农业大学 一种诊断用生物标志物的应用
CN112760381B (zh) * 2021-02-08 2022-11-01 复旦大学附属中山医院 一种检测肺腺癌预后的miRNA试剂盒
KR102310302B1 (ko) * 2021-02-08 2021-10-06 을지대학교 산학협력단 엑소좀 기반 방광암 진단을 위한 정보 제공 방법
CN117802235B (zh) * 2022-09-30 2025-08-19 上海思路迪生物医学科技有限公司 血液胞外囊泡miRNA在卵巢癌诊断中的应用
CN116121377A (zh) * 2022-11-01 2023-05-16 山西医科大学 一种食管鳞癌外泌体富含的miRNA作为诊断食管鳞癌的标志物中的应用
CN117778574B (zh) * 2023-12-25 2024-09-03 山东中医药大学 Mir937基因组拷贝数扩增在卵巢癌诊断和/或治疗中的应用
CN118421798B (zh) * 2024-05-22 2025-02-07 南通市海门区人民医院 用于检测结直肠癌相关血清生物标志物、sers传感器及制备方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030064949A1 (en) 1998-02-17 2003-04-03 Loretta Nielsen Combined tumor suppressor gene therapy and chemotherapy in the treatment of neoplasms
FR2766205B1 (fr) 1997-07-16 2002-08-30 Inst Nat Sante Rech Med Nouveau procede de sensibilisation de cellules presentatrices d'antigene et nouveaux moyens pour la mise en oeuvre du procede
KR100519384B1 (ko) 2002-08-13 2005-10-06 (주)누백스 유전자 이입을 이용한 엑소좀의 제조방법 및 상기 엑소좀의 용도
CN1281279C (zh) * 2004-09-16 2006-10-25 浙江大学 针对表皮生长因子基因的小干扰核糖核酸分子及其用途
CA2676113C (en) * 2007-07-25 2014-07-08 University Of Louisville Research Foundation, Inc. Exosome-associated microrna as a diagnostic marker
US8455199B2 (en) * 2007-09-14 2013-06-04 The Ohio State University Research Foundation MicroRNA expression in human peripheral blood microvesicles and uses thereof
EP2197497B1 (en) * 2007-09-27 2016-06-01 ImmunoVaccine Technologies Inc. Use of liposomes in a carrier comprising a continuous hydrophobic phase for delivery of polynucleotides in vivo
EP2604704B1 (en) 2008-02-01 2018-10-03 The General Hospital Corporation Use of microvesicles in diagnosis and prognosis of brain tumor
WO2009108860A2 (en) * 2008-02-28 2009-09-03 The Ohio University Rasearch Foundation Microrna-based methods and compositions for the diagnosis, pronosis and treatment of prostate related disorders
US20110172295A1 (en) * 2008-04-11 2011-07-14 The University Of North Carolina At Chapel Hill METHODS AND COMPOSITIONS FOR THE REGULATION OF microRNA PROCESSING
EP2294196A1 (en) 2008-06-06 2011-03-16 Centre National de la Recherche Scientifique - CNRS Use of endo-lysosomal system and secreted vesicles (exosome-like) in treatments and diagnostics based on small rna and experimental study of small rna
EP3181705A1 (en) 2008-11-12 2017-06-21 Caris Life Sciences Switzerland Holdings GmbH Methods and systems of using exosomes for determining phenotypes
CA2795776A1 (en) * 2010-04-06 2011-10-13 Caris Life Sciences Luxembourg Holdings, S.A.R.L. Circulating biomarkers for disease
US10081542B2 (en) * 2010-04-20 2018-09-25 University of Florida Research Foundation, lnc. Nanozymes, methods of making nanozymes, and methods of using nanozymes
CN109432126B (zh) * 2011-03-11 2022-06-14 儿童医学中心公司 与间充质干细胞外来体相关的方法和组合物
EP2699271A4 (en) * 2011-04-20 2015-10-07 Larry J Smith METHODS AND COMPOSITIONS FOR MODULATING GENE EXPRESSION USING COMPONENTS THAT SELF-ASSEMBLED IN CELLS AND PRODUCE RNAI ACTIVITY
KR20140067001A (ko) * 2011-08-08 2014-06-03 카리스 라이프 사이언스 룩셈부르크 홀딩스, 에스.에이.알.엘. 생물지표 조성물 및 방법
US9777042B2 (en) 2011-12-15 2017-10-03 Morehouse School Of Medicine Method of purifying HIV/SIV Nef from exosomal fusion proteins
DK3076949T3 (da) 2013-12-04 2019-11-25 Univ Texas Fremgangsmåde til isolering af kræftcelle-afledte eksosomer
HUE059718T2 (hu) * 2016-09-02 2022-12-28 Dicerna Pharmaceuticals Inc 4'-foszfát analógok és azokat tartalmazó oligonukleotidok

Similar Documents

Publication Publication Date Title
JP2016520803A5 (enExample)
RU2015144212A (ru) Использование биогенеза микрорнк в экзосомах для диагностики и лечения
Dong et al. Exosome-mediated transfer of lncRNA‑SNHG14 promotes trastuzumab chemoresistance in breast cancer Retraction in/10.3892/ijo. 2022.5382
Teixeira et al. Higher circulating expression levels of miR-221 associated with poor overall survival in renal cell carcinoma patients
Cheng et al. MicroRNA-184 inhibits cell proliferation and invasion, and specifically targets TNFAIP2 in Glioma
Arantes et al. MiR-21 as prognostic biomarker in head and neck squamous cell carcinoma patients undergoing an organ preservation protocol
Zhu et al. lncRNA MALAT1 overexpression promotes proliferation, migration and invasion of gastric cancer by activating the PI3K/AKT pathway
Li et al. Six1 promotes proliferation of pancreatic cancer cells via upregulation of cyclin D1 expression
Kim et al. Dormancy signatures and metastasis in estrogen receptor positive and negative breast cancer
Ahmad et al. Up-regulation of microRNA-10b is associated with the development of breast cancer brain metastasis
Kim et al. microRNA-148a is a prognostic oncomiR that targets MIG6 and BIM to regulate EGFR and apoptosis in glioblastoma
JP2017501694A5 (enExample)
Liu et al. Plasma microRNA‑320, microRNA‑let‑7e and microRNA‑21 as novel potential biomarkers for the detection of retinoblastoma
Yang et al. tRNALys-derived fragment alleviates cisplatin-induced apoptosis in prostate cancer cells
Jiang et al. Effects of microRNA‑20a on the proliferation, migration and apoptosis of multiple myeloma via the PTEN/PI3K/AKT signaling pathway
Xu et al. Insulin-like growth factor 1 receptor (IGF-1R) as a target of MiR-497 and plasma IGF-1R levels associated with TNM stage of pancreatic cancer
Zhang et al. Unique genome-wide map of TCF4 and STAT3 targets using ChIP-seq reveals their association with new molecular subtypes of glioblastoma
Fei et al. miR-96 promotes invasion and metastasis by targeting GPC3 in non-small cell lung cancer cells
De Bruyn et al. Is tissue still the issue? The promise of liquid biopsy in uveal melanoma
Borrego-Diaz et al. A potential regulatory loop between Lin28B: miR‑212 in androgen-independent prostate cancer
Li Low expression of Mir-137 predicts poor prognosis in cutaneous melanoma patients
Caserta et al. Gender differences and miRNAs expression in cancer: implications on prognosis and susceptibility
Xu et al. miR-494 promotes progression of retinoblastoma via PTEN through PI3K/AKT signaling pathway
Sekino et al. Transcribed ultraconserved region Uc. 63+ promotes resistance to cisplatin through regulation of androgen receptor signaling in bladder cancer
Fang et al. Increased serum levels of miR-214 in patients with PCa with bone metastasis may serve as a potential biomarker by targeting PTEN